Defining molecular remission in inflammatory bowel disease: lessons from oncology.

Honap S, Dignass A, Jairath V, Danese S, Magro F, Peyrin-Biroulet L

Open source

DOI
10.1016/s2468-1253(26)00219-0
Published
2026 Nov
Container
The lancet. Gastroenterology & hepatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-26-00219-0,
  title = {Defining molecular remission in inflammatory bowel disease: lessons from oncology.},
  author = {Honap S and Dignass A and Jairath V and Danese S and Magro F and Peyrin-Biroulet L},
  year = {2026},
  journal = {The lancet. Gastroenterology \& hepatology},
  doi = {10.1016/s2468-1253(26)00219-0},
  url = {https://doi.org/10.1016/s2468-1253(26)00219-0}
}

RIS

TY  - JOUR
TI  - Defining molecular remission in inflammatory bowel disease: lessons from oncology.
AU  - Honap S
AU  - Dignass A
AU  - Jairath V
AU  - Danese S
AU  - Magro F
AU  - Peyrin-Biroulet L
PY  - 2026
JO  - The lancet. Gastroenterology & hepatology
DO  - 10.1016/s2468-1253(26)00219-0
UR  - https://doi.org/10.1016/s2468-1253(26)00219-0
ER  - 

APA

S, H., A, D., V, J., S, D., F, M., & L, P. (2026). Defining molecular remission in inflammatory bowel disease: lessons from oncology.. The lancet. Gastroenterology & hepatology. https://doi.org/10.1016/s2468-1253(26)00219-0

Source records